Literature DB >> 22143231

Is Clostridium difficile infection still a problem for hospitals?

David A Enoch1, Sani H Aliyu.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22143231      PMCID： PMC3255215          DOI： 10.1503/cmaj.111449

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

1.  The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital.

Authors:  Alan J Forster; Monica Taljaard; Natalie Oake; Kumanan Wilson; Virginia Roth; Carl van Walraven
Journal:  CMAJ       Date:  2011-12-05       Impact factor: 8.262

2.  Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.

Authors:  Jacques Pépin; Louis Valiquette; Benoit Cossette
Journal:  CMAJ       Date:  2005-09-22       Impact factor: 8.262

3.  Ontario's hospitals surpass those of Quebec in C. difficile rates.

Authors:  Ann Silversides
Journal:  CMAJ       Date:  2008-06-17       Impact factor: 8.262

4.  Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Authors:  Stuart H Cohen; Dale N Gerding; Stuart Johnson; Ciaran P Kelly; Vivian G Loo; L Clifford McDonald; Jacques Pepin; Mark H Wilcox
Journal:  Infect Control Hosp Epidemiol       Date:  2010-05       Impact factor: 3.254

5.  Meta-analysis to assess risk factors for recurrent Clostridium difficile infection.

Authors:  K W Garey; S Sethi; Y Yadav; H L DuPont
Journal:  J Hosp Infect       Date:  2008-10-31       Impact factor: 3.926

6.  Treatment with monoclonal antibodies against Clostridium difficile toxins.

Authors:  Israel Lowy; Deborah C Molrine; Brett A Leav; Barbra M Blair; Roger Baxter; Dale N Gerding; Geoffrey Nichol; William D Thomas; Mark Leney; Susan Sloan; Catherine A Hay; Donna M Ambrosino
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

7.  Activity of a dry mist hydrogen peroxide system against environmental Clostridium difficile contamination in elderly care wards.

Authors:  S Shapey; K Machin; K Levi; T C Boswell
Journal:  J Hosp Infect       Date:  2008-08-09       Impact factor: 3.926

8.  Risk factors for Clostridium difficile infection.

Authors:  G E Bignardi
Journal:  J Hosp Infect       Date:  1998-09       Impact factor: 3.926

9.  A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.

Authors:  Fred A Zar; Srinivasa R Bakkanagari; K M L S T Moorthi; Melinda B Davis
Journal:  Clin Infect Dis       Date:  2007-06-19       Impact factor: 9.079

10.  Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach.

Authors:  Carlene A Muto; Mary Kathleen Blank; Jane W Marsh; Emanuel N Vergis; Mary M O'Leary; Kathleen A Shutt; Anthony W Pasculle; Marian Pokrywka; Juliet G Garcia; Kathy Posey; Terri L Roberts; Brian A Potoski; Gary E Blank; Richard L Simmons; Peter Veldkamp; Lee H Harrison; David L Paterson
Journal:  Clin Infect Dis       Date:  2007-10-09       Impact factor: 9.079
View more
  3 in total

Review 1.  Enigmatic Pilus-Like Endospore Appendages of Bacillus cereus Group Species.

Authors:  Ephrem Debebe Zegeye; Brajabandhu Pradhan; Ann-Katrin Llarena; Marina Aspholm
Journal:  Int J Mol Sci       Date:  2021-11-16       Impact factor: 5.923

2.  Appropriateness of antimicrobial use among septic patients managed by the critical care response team: an opportunity for improvement through de-escalation.

Authors:  Saad M Al-Qahtani; Henry Baffoe-Bonnie; Aiman El-Saed; Majid Alshamrani; Abdullah Algwizani; Ali Alaklabi; Khuloud AlJoudi; Nahlah Albaalharith; Azzam Mohammed; Sajid Hussain; Hanan H Balkhy
Journal:  Antimicrob Resist Infect Control       Date:  2019-11-21       Impact factor: 4.887

3.  Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries.

Authors:  Holly Yu; Nestor Flaster; Adrian Lopez Casanello; Daniel Curcio
Journal:  Braz J Infect Dis       Date:  2020-12-05       Impact factor: 3.257
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.